Histological localization of acetyltransferases in human tissue

Cancer Letters

Volumn 143, Issue 2, 1999, Pages 99-102

  Debiec Rychter, Maria ^a   Land, Susan J ^b   King, Charles M ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b KARMANOS CANCER INSTITUTE   (United States)

^c 5009 Kelsie Court ^*  (United States)

Author keywords

Human arylamine acetyltransferase; Tissue expression

Indexed keywords

ACYLTRANSFERASE; ANTISENSE OLIGONUCLEOTIDE; ARYLAMINE ACETYLTRANSFERASE; MESSENGER RNA; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE;

ACETYLATION; ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; RNA TRANSCRIPTION; TISSUE DISTRIBUTION; TOXICOKINETICS;

ACETYLTRANSFERASES; HUMANS; IN SITU HYBRIDIZATION; ORGAN SPECIFICITY;

EID: 0032782614     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00135-4     Document Type: Article

References (14)

1. Deguchi T. Physiology and molecular biology of arylamine N-acetyltransferases. Biomed. Res. 13:1992;231-242.
2. Vatsis K.P., Weber W.W. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch. Biochem. Biophys. 301:1993;71-76.
3. Badawi A.F., Hirvonen A., Bell D.A., Lang N.P., Kadlubar F.F. Role of aromatic amine acetyltransferase, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 55:1995;5230-5237.
4. Bell D.A., Badawi A.F., Lang N.P., Ilett K.F., Kadlubar F.F., Hirvonen A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res. 55:1995;5226-5229.
5. Coroneos E., Sim E. Arylamine N-acetyltransferase activity in human cultured cell lines. Biochem. J. 294:1993;481-486.
6. Deguchi T. Physiology and molecular biology of arylamine N-acetyltransferases. Biomed. Res. 13:1992;231-242.
7. Deguchi T., Mashimo M., Suzuki T. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. Biol. Chem. 267:1990;18140-18147.
8. Ilet K.F., Ingram D.M., Carpenter D.S., Teitel C.H., Lang N.P., Kadlubar F.F., Minchin R.F. Expression of monomorphic and polymorphic N-acetyltransferases in human colon. Biochem. Pharmacol. 47:1994;914-917.
9. Debiec-Rychter M., Land S.J., King C.M. Histological localization of messenger RNAs for rat acetyltransferases that acetylate serotonin and genotoxic arylamines. Cancer Res. 56:1996;1517-1522.
10. Sadrieh N., Davis C.D., Snyderwine E.G. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res. 56:1996;2683-2687.
11. Grant D.M., Blum M., Beer M., Meyer U.A. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 39:1991;184-191.
12. Hein D.W., Rustan T.D., Ferguson R.J., Doll M.A., Gray K. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch. Toxicol. 68:1994;129-133.
13. Heim M.H., Blum M., Beer M., Meyer U.A. Acetylation of serotonin in the rabbit pineal gland: an N-acetyltransferase with properties distinct from NAT1 and NAT2 is responsible. J. Neurochem. 57:1991;1095-1099.
14. Blum M., Demierre A., Grant D.M., Heim M., Meyer U.A. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. USA. 88:1991;5237-5241.